Summary
HHS issued an RFI, led by the Office of the Deputy Secretary and ASTP/ONC, seeking public input on how the Department can accelerate adoption and use of AI as part of clinical care. The notice asks stakeholders to describe promising AI use cases, barriers to adoption, and concrete actions HHS should take across regulation, reimbursement, health IT policy, and research & development to enable safe, effective, and trustworthy AI in care delivery.
Healthcare Implications
The RFI signals a coordinated, cross-HHS effort to reshape the national policy environment for clinical AI. Depending on responses, it could lead to future changes in FDA oversight of AI-enabled devices, CMS payment rules for AI-supported services, ONC health IT certification criteria, and NIH and agency funding priorities. Health systems, clinicians, patients, vendors, and payers are explicitly invited to help define guardrails, incentives, and infrastructure to support high-quality, equitable, and deflationary AI-enabled care.